Trial Profile
A Study to Evaluate the Efficacy of Addition of Dasatinib to Chemotherapy Followed by an Allogeneic Stem Cell Transplant (Allosct) in the Patients With Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Younger Than 60
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jan 2016
Price :
$35
*
At a glance
- Drugs Dasatinib (Primary) ; Cytarabine; Methotrexate; Prednisolone; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 15 Jan 2016 New trial record
- 08 Dec 2015 Results presented at the 57th Annual Meeting and Exposition of the American Society of Hematology